Show
Sort by
-
The hyperPed-COVID international registry : impact of age of onset, disease presentation and geographical distribution on the final outcome of MIS-C
-
Made in Belgium : exploring the immune horizon : systemic inflammatory diseases in the era of SARS-CoV-2 and beyond
-
Real world data on the use of lisinopril over 10 years within pediatric nephrology
-
Age-dependent signature of serum inflammatory cytokines IL-1Ra, IL-1β, IL-6, IL-18, TNF-α, CXCL9 and CXCL10 in healthy children
-
- Journal Article
- A1
- open access
Ten-year safety and clinical benefit from open-label etanercept treatment in children and young adults with juvenile idiopathic arthritis
-
Early recognotion and access to terminal complement blockers in patients with atypical HUs significantly improves their outcome : a case report
-
Real-world evidence of lisinopril in pediatric hypertension and nephroprotective management : a 10-year cohort study
-
- Journal Article
- A2
- open access
Early recognition and access to terminal complement blockers in patients with atypical HUS significantly improves their outcome : a case report
-
Acute aminoglycoside overdose : management and risks
-
- Journal Article
- A1
- open access
Comparison of SARS-CoV-2 seroconversion in children with chronic diseases with healthy children and adults during the first waves of the COVID-19 pandemic